113
Views
7
CrossRef citations to date
0
Altmetric
Articles

ABO blood group is a risk factor for coronary artery disease in patients with poor blood pressure control

, , , , , , , , & show all
Pages 366-370 | Received 27 Jul 2016, Accepted 22 Nov 2016, Published online: 17 May 2017
 

ABSTRACT

Background: Few studies had examined the role of ABO blood groups on CAD in hypertensive patients with different blood pressure (BP) controls. Methods: A total of 2708 patients with primary hypertension (HTN) were consecutively enrolled and underwent coronary angiography (CAG) due to angina-like chest pain. The severity of coronary artery stenosis was assessed by Gensini score (GS). Patients were divided into two groups due to results of CAG: HTN with CAD (n = 2185) and HTN without CAD (n = 523). Poor BP control was defined as systolic BP (SBP) ≥ mean in the study. Multivariable regression analysis was used to determine the potential impact of ABO blood groups on risk of the presence and severity of CAD. Results: Compared to HTN without CAD group, the percentage of A blood group was statistically higher and O blood group was significantly lower in HTN with CAD group. Moreover, percentage of the angiography-proven CAD was higher in A blood group than that in non-A blood group (p < 0.05). After adjusting for confounding factors, A blood group was independently associated with CAD (odds ratio (OR): 1.422; 95% confidence interval (CI): 1.017–1.987; p = 0.039) and GS (β = 0.055, p = 0.046) in patients with poor BP control. Conclusions: A blood group was an independent risk factor for the presence and severity of CAD in hypertensive patients with poor BP control.

Declaration of interest

The authors declare that they have no conflict of interest.

Funding

This study was partly supported by the National Natural Scientific Foundation (81241121), Capital Special Foundation of Clinical Application Research (Z121107001012015), Capital Health Development Fund (2011400302) and Beijing Natural Scientific Foundation (7131014) awarded to Dr. Jianjun Li, MD, PhD.

Additional information

Funding

This study was partly supported by the National Natural Scientific Foundation (81241121), Capital Special Foundation of Clinical Application Research (Z121107001012015), Capital Health Development Fund (2011400302) and Beijing Natural Scientific Foundation (7131014) awarded to Dr. Jianjun Li, MD, PhD.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.